The Clinical Outcomes and Therapeutic Effects in Patients With Cardiac Implantable Electronic Device-detected Subclinical and Clinical Atrial Fibrillation.

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 450 participants.

Also called NCT07649109

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 450 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07649109
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Taiwan (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07649109. Randomized; no masking; primary purpose treatment. Start 2025-10-01 (actual); primary completion 2027-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Clinical Outcomes and Therapeutic Effects in Patients With Cardiac Implantable Electronic Device-detected Subclinical and Clinical Atrial Fibrillation.
Acronym
AHRE
Condition
Subclinical Atrial Fibrillation
Condition
Cardiac Arrhythmias
Intervention (Other)
Early Rhythm Control Strategy
Intervention (Other)
Usual Care
Lead sponsor
National Taiwan University Hospital (class: other)

Record details

Record id
cardio:ct-nct07649109
Content hash
d00c035ce479c0a9b1cc95096ed28c85e36d3fb1f4e39108454fd18cada92b0a